The research advance of biofilm in the mechanisms of azole resistance to Candida albicans

doi:10.3969/j.issn.1673-8640.2014.06.028

Abstract

Abstract: Candida albicans is the most important opportunistic fungus. As the first choice to treat the infection, azole is widely used, but the resistance to azole is more and more common. In the lately years, researchers have focused on the mechanism of azole resistance and biofilm formation. This review summarizes the research advance of biofilm.

Key words: Candida albicans, Azole, Resistance mechanism, Biofilm

CLC Number:

R446.5

Cite this article

SHI Ce, LIU Jinyan, WEI Bing, XIANG Mingjie. The research advance of biofilm in the mechanisms of azole resistance to Candida albicans[J]. , 2014, 29(6): 692-694.

share this article

0
/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2014.06.028

https://www.shjyyx.com/EN/Y2014/V29/I6/692

References

[1] 吴晓鸥, 张德亭, 罗涛, 等. 293例妊娠妇女阴道念珠菌病的病原学特征及耐药率分析[J] . 检验医学,2008,23(5): 497-499.
[2] 史文娜,孙淑娟. 白念珠菌生物膜的研究[J] . 生命的化学,2008,28(5): 658-661.
[3] 王焕丽,陈兴平. 白念珠菌生物膜及其形成的抑制性因素研究进展[J] . 中国真菌学杂志,2009,4(6): 381-384.
[4] Cal1ş kan S,Ke?eli Özcan S, C1nar S, et al. In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints [J] . Mikrobiyol Bul,2011,45(4): 697-706.
[5] Ciok-Pater E, Biaucha A, Gospodarek E, et al. Susceptibility to antifungal agents of Candida sp. and biofilm formation [J] .Med Dosw Mikrobiol,2011, 63(2): 171-187.
[6] Uppuluri P, Srinivasan A, Ramasubramanian A, et al. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion [J] . Antimicrob Agents Chemother, 2011, 55(7): 3591-3593.
[7] Iigo M, Pemán J, Del Pozo JL. Antifungal activity against Candida biofilms [J] . Int J Artif Organs,2012, 35(10):780-791.
[8] Nett JE, Sanchez H, Cain MT, et al. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan [J] . J Infect Dis,2010,202(1): 171-175.
[9] Nett JE, Sanchez H, Cain MT, et al. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation [J] . Eukaryot Cell, 2011,10(12): 1660-1669.
[10] Nailis H, Vandenbosch D, Deforce D, et al. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms [J] .Res Microbiol,2010, 161(4): 284-292.
[11] Bink A, Govaert G, Vandenbosch D, et al. Transcription factor Efg1 contributes to the tolerance of Candida albicans biofilms against antifungal agents in vitro and in vivo [J] . J Med Microbiol,2012,61(Pt 6): 813-819.
[12] Bink A, Vandenbosch D, Coenye T, et al. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole [J] . Antimicrob Agents Chemother,2011, 55(9): 4033-4037.
[13] Cleary IA, MacGregor NB, Saville SP, et al. Investigating the function of Ddr48p in Candida albicans[J] . Eukaryot Cell,2012,11(6): 718-724.
[14] Robbins N, Uppuluri P, Nett J, et al. Hsp90 governs dispersion and drug resistance of fungal biofilms [J] .PLoS Pathog,2011, 7(9): e1002257.
[15] Shapiro RS, Zaas AK, Betancourt-Quiroz M, et al. The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance [J] . PLoS One,2012, 7(9): e44734.
[16] Yi S, Sahni N, Daniels KJ, et al. Alternative mating type configurations (a/α versus a/a or α/α) of Candida albicans result in alternative biofilms regulated by different pathways [J] . PLoS Biol,2011, 9(8): e1001117.
[17] Coleman JJ, Okoli I, Tegos GP, et al. Characterization of plant-derived saponin natural products against Candida albicans[J] . ACS Chem Biol,2010, 5(3):321-332.
[18] Khan MS, Ahmad I. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans[J] . J Ethnopharmacol,2012, 140(2): 416-423.
[19] Khan MS, Ahmad I. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms [J] . J Antimicrob Chemother,2012,67(3): 618-621.
[20] Shi W, Chen Z, Chen X, et al. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents [J] .FEMS Yeast Res,2010,10(7): 885-893.
[21] Yu LH, Wei X, Ma M, et al. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm [J] . Antimicrob Agents Chemother,2012,56(2): 770-775.
[22] Srinivasan A, Uppuluri P, Lopez-Ribot J, et al. Development of a high throughput Candida albicans biofilm chip [J] .PLoS One,2011, 6(4): e19036.

Related Articles 15

[1] FEI Bing, LIU Ying, REN Yanying, GUO Mengyu, LIU Xinwei, LIU Dongmei, LI Yongwei. Research progress of cyclic diguanylate on the regulation of Pseudomonas aeruginosa biofilm [J]. Laboratory Medicine, 2023, 38(2): 186-189.

[2] SUN Wei, XIA Shuai, FAN Yujian, MA Liyan. Drug resistance and biofilm formation abilities of Corynebacterium striatum with different genotypes [J]. Laboratory Medicine, 2022, 37(6): 505-509.

[3] ZHANG Yaru, LING Liyan, CHEN Min. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing against Candida albicans [J]. Laboratory Medicine, 2022, 37(10): 974-978.

[4] WANG Lixin, SU Yunfu, WANG Yi. Research progress on the drug resistance mechanism of clinical pathogens to fosfomycin [J]. Laboratory Medicine, 2022, 37(10): 993-997.

[5] ZHANG Guanyi, YAO Dongting, WANG Jian, HU Xiaobo. Research progress on Chinese and western medicine treatment for Candida glabrata infection [J]. Laboratory Medicine, 2021, 36(7): 761-765.

[6] ZHOU Yanxia, JIN Dongfang. Inhibition and mechanism of tannic acid on biofilm formation in Klebsiella pneumoniae [J]. Laboratory Medicine, 2021, 36(10): 1070-1073.

[7] LI Chanchan, WANG Ru, LUO Wenying. Research progress of Pseudomonas aeruginosa transcription factor PsrA [J]. Laboratory Medicine, 2020, 35(8): 832-836.

[8] LI Zhen, YIN Hongmei, CHEN Weiqin, XUE Yingjun, HU Jun, ZHU Bin, HU Xiaobo. Activity of pseudolaric acid B combined with fluconazole against Candida albican in vitro [J]. Laboratory Medicine, 2020, 35(7): 663-667.

[9] WANG Jianglin, SUN Jie, YANG Huijian, WANG Bingjie, PAN Fen, ZHANG Hong. Resistance mechanism and homology of ampicillin-resistant Haemophilus influenzae in children [J]. Laboratory Medicine, 2020, 35(6): 513-518.

[10] ZHONG Feng, FENG Yi, ZHANG Jingjing, XU Yan, FANG Yongmei, TAO Xiubin, WU Jing. In vitro antimicrobial activity and biofilm inhibitory effect of imipenem combined with tigecycline against mucoid Pseudomonas aeruginosa [J]. Laboratory Medicine, 2020, 35(6): 519-523.

[11] SUN Kangde, ZHANG Jiasheng, CHEN Xu, YU Zhongmin, CHEN Fuxiang. Correlations of virulence factor expression and drug resistance for Candida albicans isolated from oral cavity [J]. Laboratory Medicine, 2019, 34(8): 730-735.

[12] ZHANG Xinyu, DU Xuefei, ZOU Guiling, JIANG Xiaofeng. Research progress of tigecycline resistance mechanism for Acinetobacter baumannii [J]. Laboratory Medicine, 2019, 34(7): 656-660.

[13] WANG Weicheng, YANG Qiong. Correlation between serum fetuin A level and insulin resistance in patients with hyperthyroidism [J]. Laboratory Medicine, 2019, 34(10): 901-904.

[14] LI Wei, AI Fuqi, MA Yimin, WANG Bei, TIAN Yueru. Drug resistance mechanism of carbapenem resistant Providencia rettgeri carrying bla_NDM-1 [J]. Laboratory Medicine, 2019, 34(1): 67-70.

[15] XU Weixin, SUN Jie. Multilocus sequence typing in the molecular epidemiological study of azole-resistant Candida albicans from patients with Candida albicans vaginitis [J]. Laboratory Medicine, 2018, 33(3): 233-238.

Recommended Articles

Metrics

Viewed

Full text

Abstract

Abstract

References

Related Articles

Recommended Articles

Metrics

TOP

The research advance of biofilm in the mechanisms of azole resistance to Candida albicans

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	FEI Bing, LIU Ying, REN Yanying, GUO Mengyu, LIU Xinwei, LIU Dongmei, LI Yongwei. Research progress of cyclic diguanylate on the regulation of Pseudomonas aeruginosa biofilm [J]. Laboratory Medicine, 2023, 38(2): 186-189.
[2]	SUN Wei, XIA Shuai, FAN Yujian, MA Liyan. Drug resistance and biofilm formation abilities of Corynebacterium striatum with different genotypes [J]. Laboratory Medicine, 2022, 37(6): 505-509.
[3]	ZHANG Yaru, LING Liyan, CHEN Min. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing against Candida albicans [J]. Laboratory Medicine, 2022, 37(10): 974-978.
[4]	WANG Lixin, SU Yunfu, WANG Yi. Research progress on the drug resistance mechanism of clinical pathogens to fosfomycin [J]. Laboratory Medicine, 2022, 37(10): 993-997.
[5]	ZHANG Guanyi, YAO Dongting, WANG Jian, HU Xiaobo. Research progress on Chinese and western medicine treatment for Candida glabrata infection [J]. Laboratory Medicine, 2021, 36(7): 761-765.
[6]	ZHOU Yanxia, JIN Dongfang. Inhibition and mechanism of tannic acid on biofilm formation in Klebsiella pneumoniae [J]. Laboratory Medicine, 2021, 36(10): 1070-1073.
[7]	LI Chanchan, WANG Ru, LUO Wenying. Research progress of Pseudomonas aeruginosa transcription factor PsrA [J]. Laboratory Medicine, 2020, 35(8): 832-836.
[8]	LI Zhen, YIN Hongmei, CHEN Weiqin, XUE Yingjun, HU Jun, ZHU Bin, HU Xiaobo. Activity of pseudolaric acid B combined with fluconazole against Candida albican in vitro [J]. Laboratory Medicine, 2020, 35(7): 663-667.
[9]	WANG Jianglin, SUN Jie, YANG Huijian, WANG Bingjie, PAN Fen, ZHANG Hong. Resistance mechanism and homology of ampicillin-resistant Haemophilus influenzae in children [J]. Laboratory Medicine, 2020, 35(6): 513-518.
[10]	ZHONG Feng, FENG Yi, ZHANG Jingjing, XU Yan, FANG Yongmei, TAO Xiubin, WU Jing. In vitro antimicrobial activity and biofilm inhibitory effect of imipenem combined with tigecycline against mucoid Pseudomonas aeruginosa [J]. Laboratory Medicine, 2020, 35(6): 519-523.
[11]	SUN Kangde, ZHANG Jiasheng, CHEN Xu, YU Zhongmin, CHEN Fuxiang. Correlations of virulence factor expression and drug resistance for Candida albicans isolated from oral cavity [J]. Laboratory Medicine, 2019, 34(8): 730-735.
[12]	ZHANG Xinyu, DU Xuefei, ZOU Guiling, JIANG Xiaofeng. Research progress of tigecycline resistance mechanism for Acinetobacter baumannii [J]. Laboratory Medicine, 2019, 34(7): 656-660.
[13]	WANG Weicheng, YANG Qiong. Correlation between serum fetuin A level and insulin resistance in patients with hyperthyroidism [J]. Laboratory Medicine, 2019, 34(10): 901-904.
[14]	LI Wei, AI Fuqi, MA Yimin, WANG Bei, TIAN Yueru. Drug resistance mechanism of carbapenem resistant Providencia rettgeri carrying bla_NDM-1 [J]. Laboratory Medicine, 2019, 34(1): 67-70.
[15]	XU Weixin, SUN Jie. Multilocus sequence typing in the molecular epidemiological study of azole-resistant Candida albicans from patients with Candida albicans vaginitis [J]. Laboratory Medicine, 2018, 33(3): 233-238.